H J Sutherland
Overview
Explore the profile of H J Sutherland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abou-Mourad Y, Lau B, Barnett M, Forrest D, Hogge D, Nantel S, et al.
Bone Marrow Transplant
. 2009 Jul;
45(2):295-302.
PMID: 19597425
We analyzed the late outcomes of 429 long-term survivors post allogeneic hematopoietic SCT (allo-HSCT) who received transplant in our center between 1981 and 2002, and were free of their primary...
2.
Ramadan K, Connors J, Al-Tourah A, Song K, Gascoyne R, Barnett M, et al.
Bone Marrow Transplant
. 2008 Aug;
42(9):601-8.
PMID: 18695664
Outcome is poor with conventional therapy for relapsed transformed non-Hodgkin's lymphoma (NHL). Autologous SCT has been successfully employed; however the impact of allogeneic SCT has not been well defined. We...
3.
Nevill T, Hogge D, Toze C, Nantel S, Power M, Abou Mourad Y, et al.
Bone Marrow Transplant
. 2008 Aug;
42(10):659-66.
PMID: 18679372
Administration of alkylating agents (Alk), topoisomerase II inhibitors (Topo II) and radiotherapy (RT) can result in therapy-related myelodysplastic syndrome or acute myelogenous leukaemia (t-MDS/t-AML), the optimal treatment for which is...
4.
Halim T, Song K, Barnett M, Forrest D, Hogge D, Nantel S, et al.
Ann Oncol
. 2007 Apr;
18(7):1246-52.
PMID: 17442662
Background: Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly susceptible to infection. Traditionally these high-risk patients were treated as inpatients....
5.
Song K, Barnett M, Gascoyne R, Chhanabhai M, Forrest D, Hogge D, et al.
Ann Oncol
. 2006 Dec;
18(3):535-40.
PMID: 17158775
Background: Controversy exists regarding the role of high-dose therapy followed by stem-cell transplant (SCT) in the treatment of T-cell lymphoblastic lymphoma (T-LBL). We conducted an intention-to-treat analysis of the strategy...
6.
Greenwood M, Seftel M, Richardson C, Barbaric D, Barnett M, Bruyere H, et al.
Leuk Lymphoma
. 2006 Aug;
47(7):1245-52.
PMID: 16923553
Acute myeloid leukemia (AML) presenting with a high leukocyte count has been associated with an increase in induction mortality and poor results in a number of other survival measures. However,...
7.
Savoie M, Nevil T, Song K, Forrest D, Hogge D, Nantel S, et al.
Ann Oncol
. 2006 Feb;
17(5):763-8.
PMID: 16497826
Background: We assessed the feasibility of outpatient chemotherapy and supportive care in patients with acute myeloid leukemia (AML). Patients And Methods: All patients receiving curative intent chemotherapy between 09/01 and...
8.
Toze C, Galal A, Barnett M, Shepherd J, Conneally E, Hogge D, et al.
Bone Marrow Transplant
. 2005 Sep;
36(9):825-30.
PMID: 16151430
In all, 30 patients with CLL proceeded to myeloablative allogeneic BMT using related (n=20, 67%) or unrelated (n=10) donors, at the Princess Margaret Hospital (Toronto) (n=20) or the Leukemia/BMT Program...
9.
Kuruvilla J, Forrest D, Lavoie J, Nantel S, Shepherd J, Song K, et al.
Bone Marrow Transplant
. 2004 Oct;
34(11):969-73.
PMID: 15489882
Endocarditis is an uncommon complication of hematopoietic stem cell transplantation (HSCT). A retrospective review of 1547 patients who underwent HSCT in Vancouver between January 1986 and December 2001 was performed....
10.
Roth A, Vercauteren S, Sutherland H, Lansdorp P
Leukemia
. 2003 Oct;
17(12):2410-7.
PMID: 14562114
Telomeres play an important role in the proliferation and senescence of normal and malignant cells. To test the role of telomerase in acute myeloid leukemia (AML), we expressed the telomerase...